drugset / Trial / NCT00293878

Study on the Safety and Effects on Lipids of FM-VP4 in Subjects With Primary Hypercholesterolemia

NCT00293878 ↗

Phase 2 Completed 150 enrolled Forbes Medi-Tech
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the safety and effects on lipids of FM-VP4 administered for 12 weeks in subjects with mild to moderate primary hypercholesterolemia.

Timeline

Start
2005-11
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Disodium Ascorbyl Phytostanol Phosphate Unknown — —

Indications